RotaTeq® and Meningococcus C Vaccine in Healthy Infants

Update Il y a 5 ans
Reference: NCT00443846

Woman and Man

  • | Country :
  • Finland
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Primary objective: To check if RotaTeq® can be administered concomitantly with meningococcal Group C vaccine without impairing the efficacy of MCC vaccine. Secondary objectives: - Efficacy: Additional immunogenicity assessments. - Safety: To describe the safety profile of RotaTeq® and of the MCC vaccine when administered concomitantly with RotaTeq®.


Inclusion criteria

  • Meningitis, Meningococcal ,Rotavirus Infections

Links